CME Group (NASDAQ:CME) Posts Record H1 2026 With $1.7B Q2 Revenue and $238M Market Data High

CME Group (NASDAQ: CME) reported Q2 2026 revenue of $1.7 billion and adjusted EPS of $2.99, beating the $2.94 consensus estimate by 1.8%, as the company logged what it called the strongest first half in its history. Shares gained 5.00% on Wednesday, July 22, while the S&P 500 slipped 0.12%.

Q2 2026 Results

• Revenue: $1.7 billion for Q2 2026, with GAAP operating income of $1.1 billion and a GAAP operating margin of 64.7%.
• Adjusted figures: Adjusted operating income of $1.2 billion; adjusted net income of $1.1 billion; adjusted EPS of $2.99 vs. the $2.94 consensus estimate.
• GAAP EPS: $2.88 diluted; GAAP net income of $1.0 billion.
• Market data revenue: A record $238 million in Q2, up 20% year over year.
• Average daily volume (ADV): 29.8 million contracts, the third-highest quarterly ADV in CME's history, including non-U.S. ADV of 9.1 million contracts.
• Clearing and transaction fees: $1.4 billion for the quarter; total average rate per contract of $0.678.

What Drove the Results

Adjusted EPS of $2.99 beat the $2.94 consensus by $0.05, or 1.8%. No revenue consensus figure was available for a direct comparison. The GAAP EPS of $2.88 trails the adjusted figure by $0.11, a gap attributable to items excluded in CME's non-GAAP reconciliation.

Market data revenue of $238 million was the primary standout, rising 20% year over year to a record level. CME Group Chairman and CEO Terry Duffy noted the company also provided more than $95 billion in daily margin efficiencies during the quarter, which he described as a new high. Clearing and transaction fee revenue of $1.4 billion was supported by the 29.8 million contract ADV, the third-highest quarterly figure on record.

The company also highlighted several new product initiatives during the quarter, including Single-Stock futures, 1-Ounce Gold contracts available around the clock, U.S. Treasury clearing, and Compute futures. Looking ahead, CME plans to launch Sorghum basis futures in August 2026, a contract focused on the price relationship between sorghum and corn and designed to offer additional risk management tools to agricultural producers and traders, using existing grain infrastructure in Kansas.

On the balance sheet, CME held $2.3 billion in cash as of June 30, 2026, against $3.4 billion of debt. During Q2, the company paid approximately $468 million in dividends and repurchased $695 million in common shares.

Wall Street View

Analyst sentiment heading into the print leaned constructive, with the consensus as of July 1, 2026 reflecting 10 Buy ratings, 2 Strong Buy, 6 Hold, and 3 Sell recommendations. No specific price target changes were available in the source data following today's release.

Investor Takeaway

The Q2 beat was driven not just by trading volume but by the accelerating market data segment, which at $238 million represents a higher-margin, recurring revenue stream that is less dependent on quarter-to-quarter volatility in contract ADV. With H1 2026 marking a record across revenue, adjusted operating income, adjusted net income, and adjusted EPS, the key forward question is whether the third-highest-ever quarterly ADV of 29.8 million contracts signals a structural step-up in trading activity or a temporary spike, particularly as CME expands into new product categories including Single-Stock futures and U.S. Treasury clearing.